Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 2/2012

Inhalt (23 Artikel)

Review

Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials

Fausto Petrelli, Karen Borgonovo, Mary Cabiddu, Veronica Lonati, Sandro Barni

Original Paper

Histopathology of surgically treated renal tumours in young adults: a developing country perspective

Muhammed Mubarak, Javed I. Kazi, Rehan Mohsin, Altaf Hashmi, Syed Ali Anwer Naqvi, Syed Adeeb ul Hassan Rizvi

Original Paper

Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo

Yong Liu, Changyun Yu, Yuanzheng Qiu, Donghai Huang, Xiaojuan Zhou, Xin Zhang, Yongquan Tian

Original Paper

Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing cells: a potential mechanism of altered leukemogenicity

Nicolai Härtel, Thomas Klag, Benjamin Hanfstein, Martin C. Mueller, Thomas Schenk, Philipp Erben, Andreas Hochhaus, Paul La Rosée

Original Paper

PAX3/7–FOXO1 fusion status in older rhabdomyosarcoma patient population by fluorescent in situ hybridization

Sarah N. Dumont, Alexander J. Lazar, Julia A. Bridge, Robert S. Benjamin, Jonathan C. Trent

Open Access Original Paper

Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer

Maurizio Belfiglio, Caterina Fanizza, Nicola Tinari, Corrado Ficorella, Stefano Iacobelli, Clara Natoli

Original Paper

A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with late-stage non-small cell lung cancer

Jian Cheng, Minwen Ha, Yadi Wang, Jing Sun, Junchen Chen, Yue Wang, Chunyan Tong

Original Paper

ARK5 is associated with the invasive and metastatic potential of human breast cancer cells

Xin-Zhong Chang, Jie Yu, Hai-Yin Liu, Rui-Hua Dong, Xu-Chen Cao

Original Paper

Nodal status—its impact on prognosis in advanced ovarian cancer

C. Bachmann, S. Bachmann, T. Fehm, A. Staebler, S. Becker, R. Rothmund, C. Gardanis, E. M. Grischke, D. Wallwiener, E. F. Solomayer

Original Paper

Growth pattern of renal cell carcinoma (RCC) in patients with delayed surgical intervention

Xue-Song Li, Lin Yao, Kan Gong, Wei Yu, Qun He, Li-Qun Zhou, Zhi-Song He

Original Paper

High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients

Yanan Kong, Shuqin Dai, Xinhua Xie, Xiangsheng Xiao, Ning Lv, Jiaoli Guo, Laisheng Li, Weihua Jia, Yin Zhang, Wanli Liu, Weidong Wei, Xiaoming Xie

Original Paper

Hox B4 as potential marker of non-differentiated cells in human cervical cancer cells

Ana P. Barba-de la Rosa, Erika Briones-Cerecero, Ofelia Lugo-Melchor, Antonio De León-Rodríguez, Leticia Santos, Julio Castelo-Ruelas, Alejandra Valdivia, Patricia Piña, Alicia Chagolla-López, Daniel Hernandez-Cueto, Alejandra Mantilla, Minerva Lazos-Ochoa, Beatriz Gonzalez-Yebra, Mauricio Salcedo

Original Paper

Palliative considerations in the surgical treatment of spinal metastases

Jan Walter, Rupert Reichart, Albrecht Waschke, Rolf Kalff, Christian Ewald

Original Paper

The role of leptin receptor gene polymorphisms in determining the susceptibility and prognosis of NSCLC in Chinese patients

Yuliang Li, Jianli Geng, Yongzheng Wang, Qinghua Lu, Yimeng Du, Wujie Wang, Zheng Li

Original Paper

Histone deacetylase inhibitor potentiates chemotherapy-induced apoptosis through Bim upregulation in Burkitt’s lymphoma cells

Ana Carolina dos Santos Ferreira, Renan Amphilophio Fernandes, Jolie Kiemlian Kwee, Claudete Esteves Klumb

Original Paper

Evaluation of oral chemotherapy with capecitabine and cyclophosphamide plus thalidomide and prednisone in prostate cancer patients

Li-Juan Meng, Jun Wang, Wei-Fei Fan, Xiao-Lin Pu, Fu-Yin Liu, Min Yang

Original Paper

Oral tongue cancer patients show a better overall survival than base of tongue cancer patients

Liuyang Zhang, Xuan Zhou, Xiaofeng Yao, Yansheng Wu, Qiang Zhang, Lun Zhang

Rapid Communication

Mutational activation of FGFR3: no involvement in the development of renal cell carcinoma

C. G. Stoehr, R. Stoehr, A. Hartmann, F. Hofstaedter, K. Junker, H. Blaszyk, W. F. Wieland, W. Otto, S. Denzinger, B. Walter

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.